Zhen Lou

Zhen Lou has worked in the pharmaceutical industry since 2001. Starting at Pfizer as a Senior Scientist-Principal Scientist, Lou then moved to Bristol-Myers Squibb (BMS) in 2007 as a Senior Research Investigator I-II. In 2014, Lou joined Shire as a Director, DMPK Group Lead and Associate Director. In 2019, Lou took on the role of Director, DMPK Group Lead at Takeda and Executive Director, Head of Preclinical Development (DMPK and Drug Safety) at H3 Biomedicine. Lou currently holds the position of VP, Head of Translational Medicine at Cardurion Pharmaceuticals.

Zhen Lou completed a Ph.D. in Drug Metabolism and Toxicology from the University of Florida between 1997 and 2001.